Brave New World Panel discussion at Pharma Integrates 2020. 17th November 2020. What are we doing differently now that’s better than before? What do we foresee might be future benefits of new ways of working?
Facilitated by: Tina Flatau, CEO, Biopharma Projects
Panelists include: Graham Wylie, CEO, MRN Flic Gabbay, Managing Partner, transcript David Hawkins, Founder & CEO, Remedium Capital Helen Barker, Head of Pharmaceutical Development, Reneo Pharma Sean Breen, Head Public-Private Partnerships and Science Policy, Takeda